US Bancorp’s Vanda Pharmaceuticals VNDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-27,244
Closed -$128K 4249
2024
Q3
$128K Sell
27,244
-1,143
-4% -$5.36K ﹤0.01% 2274
2024
Q2
$160K Hold
28,387
﹤0.01% 2104
2024
Q1
$117K Sell
28,387
-2,529
-8% -$10.4K ﹤0.01% 2275
2023
Q4
$130K Buy
30,916
+30,555
+8,464% +$129K ﹤0.01% 2221
2023
Q3
$1.56K Sell
361
-2,607
-88% -$11.3K ﹤0.01% 3679
2023
Q2
$19.6K Buy
2,968
+2,607
+722% +$17.2K ﹤0.01% 2963
2023
Q1
$2.45K Sell
361
-138
-28% -$937 ﹤0.01% 3686
2022
Q4
$3.69K Hold
499
﹤0.01% 3600
2022
Q3
$5K Sell
499
-1,032
-67% -$10.3K ﹤0.01% 3604
2022
Q2
$17K Buy
1,531
+480
+46% +$5.33K ﹤0.01% 3140
2022
Q1
$12K Buy
1,051
+844
+408% +$9.64K ﹤0.01% 3302
2021
Q4
$3K Hold
207
﹤0.01% 3806
2021
Q3
$4K Sell
207
-639
-76% -$12.3K ﹤0.01% 3702
2021
Q2
$18K Hold
846
﹤0.01% 3186
2021
Q1
$13K Buy
846
+400
+90% +$6.15K ﹤0.01% 3190
2020
Q4
$6K Sell
446
-478
-52% -$6.43K ﹤0.01% 3344
2020
Q3
$9K Sell
924
-611
-40% -$5.95K ﹤0.01% 3074
2020
Q2
$17K Sell
1,535
-514
-25% -$5.69K ﹤0.01% 2837
2020
Q1
$22K Sell
2,049
-1,213
-37% -$13K ﹤0.01% 2652
2019
Q4
$53K Sell
3,262
-3,364
-51% -$54.7K ﹤0.01% 2447
2019
Q3
$88K Sell
6,626
-19,741
-75% -$262K ﹤0.01% 2226
2019
Q2
$372K Sell
26,367
-13,686
-34% -$193K ﹤0.01% 1548
2019
Q1
$737K Buy
40,053
+6,845
+21% +$126K ﹤0.01% 1207
2018
Q4
$868K Buy
33,208
+6,118
+23% +$160K ﹤0.01% 1084
2018
Q3
$621K Buy
27,090
+26,782
+8,695% +$614K ﹤0.01% 1343
2018
Q2
$6K Buy
308
+148
+93% +$2.88K ﹤0.01% 3291
2018
Q1
$3K Sell
160
-3,064
-95% -$57.5K ﹤0.01% 3438
2017
Q4
$49K Buy
3,224
+2,924
+975% +$44.4K ﹤0.01% 2613
2017
Q3
$5K Hold
300
﹤0.01% 3276
2017
Q2
$5K Hold
300
﹤0.01% 3239
2017
Q1
$4K Buy
+300
New +$4K ﹤0.01% 3275